Huang SH , Lewis TM , Lummis SC , Thompson AJ , Chebib M , Johnston GA , Duke RK .

Wellcome Trust

	Fig. 1. Structures of ginkgolides A, B and C (GA, GB and GC) (20 carbon atoms), bilobalide (15 carbon atoms) and picrotoxinin (PTX) (15 carbon atoms). These compounds have cavity-like structures made up of a highly oxygenated carbon skeleton, including two lactone rings and an epoxy group in PTX, and three lactone rings in bilobalide and ginkgolides. The lipophilic side chain (isopropenyl group in PTX and t-butyl group in bilobalide and ginkgolides) is attached to the underside of the cavity. Ginkgolides A, B and C have two common hydroxyl groups at C3 and C10 as shown in ginkgolide A. The hydroxyl group at C10 is located at the top and the C3 hydroxyl underneath the main cage comprising rings F, A, D and C. Two additional rings E and B project outward from the main cage. The C3 hydroxyl of the ginkgolides is next to the polar lactone ring E whereas the only hydroxyl group in PTX is located at the nonpolar underside of the cage. Note that ginkgolide A lacks the hydroxyl at C1 which acts as an H-bond donor to the C10 hydroxyl in ginkgolides B and C. The C7 in ginkgolide C projects upwards to the oxolane ring D.
	Fig. 2. Current traces produced by 1.2 μM GABA (EC50, solid bar) in the presence of (A) ginkgolide A, (B) ginkgolide B and (C) ginkgolide C at various concentrations from human ρ1 GABAC receptors expressed in Xenopus oocytes. The bars indicate duration of drug application. The ginkgolides did not have any effect on their own when tested at 100 μM.
	Fig. 3. Agonist concentration–response curves for GABA, in the presence and absence of (A) ginkgolide A, (B) ginkgolide B and (C) ginkgolide C from recombinant human ρ1 GABAC receptors. For each panel, the control concentration–response curve (●) is shown along with the subsequent curves obtained in the presence of 10 μM (■), 30 μM (▴) and 100 μM (▾) ginkgolide. Note the approximately parallel rightward shifts in the concentration–response curves, along with an inhibition of the maximum response with an increase in ginkgolide concentration, which is characteristic of a mixed-antagonism. The inhibition of the maximum response by ginkgolides exhibits some degree of ‘saturation’ that is most obvious for ginkgolide C. That is, there is no further inhibition of the maximum response (or a small change) with a further increase in ginkgolide concentration from 30 to 100 μM. The data are fitted with the Hill equation and the average EC50, Hill coefficients and normalized maximum responses estimated from these data are shown in Table 1. Data are mean ± S.E.M. (n = 4–6). Where the error bar is not obvious, it is entirely within the plotted symbol.
	Fig. 4. Inhibition concentration–response curves recorded from recombinant human ρ1 GABAC receptors for (A) ginkgolide A, (B) ginkgolide B and (C) ginkgolide C, in the presence of 0.5 μM (●), 1.2 μM (■), 3 μM (▴) and 10 μM () GABA. The data are fitted with the Hill equation and the average IC50 and Hill coefficients estimated from these data are shown in Table 2. Data are mean ± S.E.M. (n = 5–7 oocytes). Where the error bar is not obvious, it is entirely within the plotted symbol. Note that antagonism appears to saturate at the highest concentration of ginkgolide B.
	Fig. 5. Use-dependent effect in the antagonism of ρ1 GABAC receptors by ginkgolides. A. Examples of currents recorded during repeated co-applications of GABA and ginkgolides. The ginkgolides were applied 40 s prior to the first co-application with GABA and were continuously present until the fifth co-application. Each application was separated by a 3-min interval. B. Histogram representing the mean data of consecutive co-applications of GABA and ginkgolide A (n = 4), ginkgolide B (n = 6) and ginkgolide C (n = 4). The small increase in inhibition with the second application of ginkgolide B and C was not significant. Overall, there was no obvious evidence for use-dependent inhibition by the ginkgolides.
	Fig. 6. Recovery time from ginkgolide inhibition. Examples of current traces produced by the co-application of 5 or 50 μM ginkgolide A, B and C during the plateau phase of the response to 1 or 3 μM GABA. Note the faster recovery from block at higher GABA concentrations. The recovery times (10–90% rise times) are shown in Table 3.
	Fig. 7. Macroscopic kinetic schemes fitted to equilibrium concentration–response curve data. Scheme 1 represents the sequential mechanism of Amin and Weiss (1996), which adequately describes the homomeric ρ1 GABAC receptor function. This assumes five equivalent agonist binding sites but only three are required to be occupied to activate (open) the channel pore. All subsequent kinetic schemes are derivatives of the linear scheme, by incorporating different possible mechanisms for antagonism by ginkgolides. These are drawn from the cyclic mixed-antagonism mechanism described by Smart and Constanti (1986). Scheme 2 and scheme 3 both assume that ginkgolide binds to a single site in the receptor complex. The only difference between these schemes is that ginkgolide bound to the open state does not allow ion conduction in scheme 3 (BA3R′), while in scheme 2 the open state remains conducting (BA3R*). For scheme 4, the equilibrium between the fully-liganded closed and open states is removed, which allows for the possibility that the ginkgolide binds to a separate site in the closed state compared to the open state. In each case: R represents the receptor complex; A represents the agonist and the subscript the number of agonist molecules bound to the receptor; B represents the antagonist (blocker); the asterisk denotes the open (conducting) state of the receptor; Ka is the microscopic equilibrium constant for the agonist (GABA) and Ka′ is the microscopic agonist equilibrium constant when ginkgolide is bound to the receptor (the macroscopic equilibrium constants are shown in each of the schemes); Kb0 to Kb4 are the equilibrium constants for the ginkgolide for each state of the receptor; E is the equilibrium constant for the opening reaction of the channel pore, where E = β/α, and β is the forward rate constant and α is the reverse rate constant; and similarly E′ is the equilibrium constant when ginkgolide is bound.
	Fig. 8. Results from scheme 2 (Fig. 7). Equilibrium concentration–response curves fitted with scheme 2 for (A) ginkgolide A, (B) ginkgolide B and (C) ginkgolide C. In each case, the parameters for the response to GABA alone were fixed (Ka = 3.2 μM and E = 11) to improve the precision on the remaining parameters estimated. All parameters for the fit were shared across the data sets for each ginkgolide with the exception of the concentration of the ginkgolide (0, 10, 30 and 100 μM). The fit of scheme 2 describes well the mixed-antagonism of the data sets for ginkgolide A, B and C. Panels D–F show the predicted inhibition curves generated with the parameters obtained from the fit to the concentration–response curves exhibit saturation of inhibition, where the bottom of the curve reaches a plateau rather than a full inhibition of the response. The plotted symbols in each panel are as for Fig. 3; equilibrium concentration–response data for GABA in the absence of ginkgolide (●) and in the presence of 10 μM (■), 30 μM (▴) and 100 μM (▾) ginkgolide.
	Fig. 9. Results from scheme 3 (Fig. 7). Equilibrium concentration–response curves fitted with scheme 3 for (A) ginkgolide A, (B) ginkgolide B and (C) ginkgolide C. As for scheme 2, the parameters for the response to GABA alone were fixed (Ka = 3.2 μM and E = 11) and all other parameters were shared across the data sets for each ginkgolide with the exception of the concentration of the ginkgolide (0, 10, 30 and 100 μM). The fit with scheme 2 was noticeably worse, with the curve failing to follow the data points at the top of the concentration–response curve and consequently an increase in the standard deviation of the residuals for the fit. The predicted inhibition curves (panels D–F) exhibit complete inhibition at each of the GABA concentrations (numbers indicate 0.5, 1.2, 3.0 and 10 μM GABA). The plotted symbols in each panel are as for Fig. 3; equilibrium concentration–response data for GABA in the absence of ginkgolide (●) and in the presence of 10 μM (■), 30 μM (▴) and 100 μM (▾) ginkgolide.
	Fig. 10. A comparison of the channel from 3EAM and the ρ1 GABAC receptor homology model used in this study. The profile is plotted as the average pore diameter for the whole pentamer (solid line, ρ1 GABAC receptor homology model; dotted line, 3EAM).
	Fig. 11. Examples of the two main docked poses for ginkgolide B in the ρ1 GABAC receptor homology model. M2 helices are shown as ribbons, and apart from the side chains of residues P2′ and T6′, all others have been removed for clarity. For ginkgolide A, ginkgolide B (GB) and ginkgolide C, the orientations of the ligands were the same, and so only ginkgolide B (the most potent ligand) is shown. Panels A and D show the docked pose as seen looking from the extracellular domain, down through the receptor pore. Panels B and E are the same poses viewed from the side. Ginkgolide B is shown in stick representation. Panel C is in the same orientation as panel A, but shows an overlay of two poses, highlighting the rotation of the ginkgolide B ligand.

Amin, Insights into the activation mechanism of rho1 GABA receptors obtained by coexpression of wild type and activation-impaired subunits. 1996, Pubmed, Xenbase

Amin, Insights into the activation mechanism of rho1 GABA receptors obtained by coexpression of wild type and activation-impaired subunits. 1996, Pubmed , Xenbase
Barry, Ligand-gated channels. 2005, Pubmed
Buhr, Two novel residues in M2 of the gamma-aminobutyric acid type A receptor affecting gating by GABA and picrotoxin affinity. 2001, Pubmed , Xenbase
Carland, Mutations of the 2' proline in the M2 domain of the human GABAC rho1 subunit alter agonist responses. 2004, Pubmed , Xenbase
Carland, Charged residues at the 2' position of human GABAC rho 1 receptors invert ion selectivity and influence open state probability. 2004, Pubmed
Carland, Relative impact of residues at the intracellular and extracellular ends of the human GABAC rho1 receptor M2 domain on picrotoxinin activity. 2008, Pubmed , Xenbase
Chang, Channel opening locks agonist onto the GABAC receptor. 1999, Pubmed
Chen, Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. 2006, Pubmed
Constanti, The "mixed" effect of picrotoxin on the GABA dose/conductance relation recorded from lobster muscle. 1978, Pubmed
Das, Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. 2005, Pubmed
Dillon, Enhancement by GABA of the association rate of picrotoxin and tert-butylbicyclophosphorothionate to the rat cloned alpha 1 beta 2 gamma 2 GABAA receptor subtype. 1995, Pubmed
Dong, Use-dependent and use-independent blocking actions of picrotoxin and zinc at the GABAC receptor in retinal horizontal cells. 1996, Pubmed
Duke, (+)- and (-)-cis-2-aminomethylcyclopropanecarboxylic acids show opposite pharmacology at recombinant rho(1) and rho(2) GABA(C) receptors. 2000, Pubmed , Xenbase
Enz, A single point mutation decreases picrotoxinin sensitivity of the human GABA receptor rho 1 subunit. 1995, Pubmed
Erkkila, Stoichiometric pore mutations of the GABAAR reveal a pattern of hydrogen bonding with picrotoxin. 2008, Pubmed
Erkkila, Picrotoxin-mediated antagonism of alpha3beta4 and alpha7 acetylcholine receptors. 2004, Pubmed , Xenbase
Feigenspan, Differential pharmacology of GABAA and GABAC receptors on rat retinal bipolar cells. 1994, Pubmed
Ffrench-Constant, A point mutation in a Drosophila GABA receptor confers insecticide resistance. 1993, Pubmed , Xenbase
Filippova, Evidence that the TM1-TM2 loop contributes to the rho1 GABA receptor pore. 2004, Pubmed , Xenbase
Goutman, Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABA rho 1 receptor. 2004, Pubmed , Xenbase
Gurley, Point mutations in the M2 region of the alpha, beta, or gamma subunit of the GABAA channel that abolish block by picrotoxin. 1995, Pubmed , Xenbase
Hawthorne, Molecular determinants of ginkgolide binding in the glycine receptor pore. 2006, Pubmed
Heads, Structure-activity analysis of ginkgolide binding in the glycine receptor pore. 2008, Pubmed
Huang, Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors. 2003, Pubmed , Xenbase
Huang, Mixed antagonistic effects of bilobalide at rho1 GABAC receptor. 2006, Pubmed , Xenbase
Huang, Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. 2004, Pubmed , Xenbase
Ivic, Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA(A) receptors. 2003, Pubmed
Jensen, Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptors. 2010, Pubmed
Korshoej, Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABAA receptors by picrotoxin. 2010, Pubmed
Krishek, A functional comparison of the antagonists bicuculline and picrotoxin at recombinant GABAA receptors. 1996, Pubmed , Xenbase
Kusama, Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells. 1993, Pubmed , Xenbase
Lovell, Structure validation by Calpha geometry: phi,psi and Cbeta deviation. 2003, Pubmed
Lummis, Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. 2005, Pubmed
Miller, Binding, activation and modulation of Cys-loop receptors. 2010, Pubmed
Miyazawa, Structure and gating mechanism of the acetylcholine receptor pore. 2003, Pubmed
Newland, On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. 1992, Pubmed
Olsen, GABA A receptors: subtypes provide diversity of function and pharmacology. 2009, Pubmed
Perret, Interaction of non-competitive blockers within the gamma-aminobutyric acid type A chloride channel using chemically reactive probes as chemical sensors for cysteine mutants. 1999, Pubmed , Xenbase
Perry, NOESY on neurotoxins: NMR and conformational assignments of picrotoxins. 2001, Pubmed
Qian, Pharmacology of novel GABA receptors found on rod horizontal cells of the white perch retina. 1994, Pubmed
Qian, Focus on molecules: the GABAC receptor. 2009, Pubmed
Qian, Picrotoxin accelerates relaxation of GABAC receptors. 2005, Pubmed , Xenbase
Qian, A single amino acid in the second transmembrane domain of GABA rho subunits is a determinant of the response kinetics of GABAC receptors. 1999, Pubmed , Xenbase
Ramakrishnan, Picrotoxin inhibition mechanism of a gamma-aminobutyric acid A receptor investigated by a laser-pulse photolysis technique. 2005, Pubmed
Ramanjaneyulu, Binding characteristics and interactions of depressant drugs with [35S]t-butylbicyclophosphorothionate, a ligand that binds to the picrotoxinin site. 1984, Pubmed
Sali, Comparative protein modelling by satisfaction of spatial restraints. 1993, Pubmed
Scheller, Coupled and uncoupled gating and desensitization effects by pore domain mutations in GABA(A) receptors. 2002, Pubmed
Shi, FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. 2001, Pubmed
Smart, Studies on the mechanism of action of picrotoxinin and other convulsants at the crustacean muscle GABA receptor. 1986, Pubmed
Thompson, Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor. 2011, Pubmed , Xenbase
Thompson, A single amino acid determines the toxicity of Ginkgo biloba extracts. 2012, Pubmed , Xenbase
Twyman, Pentobarbital and picrotoxin have reciprocal actions on single GABAA receptor channels. 1989, Pubmed
Wang, A single amino acid in gamma-aminobutyric acid rho 1 receptors affects competitive and noncompetitive components of picrotoxin inhibition. 1995, Pubmed , Xenbase
Woodward, Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors. 1992, Pubmed , Xenbase
Wotring, Charge scan reveals an extended region at the intracellular end of the GABA receptor pore that can influence ion selectivity. 2008, Pubmed , Xenbase
Wotring, Mutations at the GABA receptor selectivity filter: a possible role for effective charges. 2003, Pubmed , Xenbase
Xu, Interaction of picrotoxin with GABAA receptor channel-lining residues probed in cysteine mutants. 1995, Pubmed , Xenbase
Yevenes, Allosteric modulation of glycine receptors. 2011, Pubmed
Yoon, Multiple mechanisms of picrotoxin block of GABA-induced currents in rat hippocampal neurons. 1993, Pubmed
Zhang, Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block. 1995, Pubmed , Xenbase
Zhao, Three ginkgolide hydrates from Ginkgo biloba L.: ginkgolide A monohydrate, ginkgolide C sesquihydrate and ginkgolide J dihydrate, all determined at 120 K. 2002, Pubmed
Zhorov, Chloride channels of glycine and GABA receptors with blockers: Monte Carlo minimization and structure-activity relationships. 2000, Pubmed
Zhu, A single amino acid in the second transmembrane domain of GABA rho receptors regulates channel conductance. 2007, Pubmed
van Beek, Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. 2005, Pubmed